Breaking News, Collaborations & Alliances

Forge Biologics to Support MDA’s Kickstart Program

Will help deliver potentially life-changing treatments to patients suffering from rare diseases.

Author Image

By: Charlie Sternberg

Associate Editor

Forge Biologics, a member of Ajinomoto Bio-Pharma Services and a manufacturer of genetic medicines, has been selected as the adeno-associated virus (AAV) development and manufacturing partner for the Muscular Dystrophy Association’s (MDA) Kickstart Program.   MDA is a nonprofit focused on accelerating research, advancing care, and advocating for the support of people living with muscular dystrophy, ALS, and related neuromuscular diseases. The MDA Kickstart Program is a new research program dev...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters